Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0KFTQM
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
daratumumab-I-4-0.24
|
|||||
| Synonyms |
Daratumumab-I-4-0.24
Click to Show/Hide
|
|||||
| Organization |
Kleo Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
0.24
|
|||||
| Structure |
|
|||||
| Antibody Name |
Daratumumab
|
Antibody Info | ||||
| Antigen Name |
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
site-specific conjugation
|
|||||
| Combination Type |
I-4
|
|||||